User login
Improving your care of patients with spinal cord injury/disease
› Have a high index of suspicion for the leading causes of hospitalization among patients with spinal cord injury and disease (SCI/D). These include respiratory infections, urinary tract infections, and pressure ulcers. A
› Treat respiratory infections early and aggressively in patients with SCI/D; strongly consider inpatient management because of the high risk of respiratory failure. C
› Be alert to atypical signs and symptoms of urinary tract infection in patients with SCI/D, such as fever, chills, spasm, autonomic dysfunction, nausea and vomiting, abdominal discomfort, and fatigue. C
Strength of recommendation (SOR)
A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series
More than 5 million Americans are living with paralysis, and for nearly one in 4 of them the cause is spinal cord injury or disease (SCI/D).1 More common than multiple sclerosis (17%) as a cause for the loss of movement, SCI/D is second only to stroke (29%).1
The percentage of people living with paralysis due to SCI/D is increasing, partly because the population is aging and partly because management of infections has improved. Prior to the 1970s, life expectancy for people with SCI/D was significantly shortened, largely because of urologic and respiratory infections. But improved bladder management, in particular, has increased life expectancy—especially for the least severely injured.2 Respiratory diseases and septicemia remain the leading causes of death, but with increased longevity, other causes, such as endocrine, metabolic and nutritional diseases, accidents, nervous system diseases, and musculoskeletal disorders, are becoming increasingly common.2,3
Primary care’s pivotal role. Given the size of the population affected by SCI/D and the increase in life expectancy, family physicians (FPs) are more likely than ever before to care for these patients, most of whom have highly specific needs. However, little information about the primary care of patients with SCI/D exists. This patient population tends to consume a relatively large share of practices’ resources because of high case complexity.4
A recent Canadian report confirms our clinical experience that FPs report knowledge gaps in the area of SCI/D care, yet the same report found that 90% of people with SCI/D identify FPs as their “regular doctors.”5 Although a large number of patients with SCI/D identify their physiatrist as their primary care physician (PCP), one study reported that fewer than half of physiatrists are willing to assume that role.6 And while more than half of all patients with SCI/D have both specialists and PCPs involved in their care,5 communication breakdowns are a concern for patients receiving medical and rehabilitative direction from multiple health care professionals.
Below we take a closer look at the distinct patient populations affected by SCI/D, summarize several clinical conditions that contribute to hospitalization, and provide clinical management recommendations (TABLE7-26).
2 patient populations, one diagnosis
Paralysis due to spinal trauma occurs predominantly in non-Hispanic white and black males because of vehicular accidents, falls, violence, and sports.2 The mean age of injury has increased from 29 years during the 1970s to 42 years since 2010.2 However, this calculated average is misleading because there is an emerging bimodal distribution of people injured during early adulthood and a new increase in older adults injured primarily because of falls.27 In addition to those injured traumatically, a broader cohort of approximately 1 million patients represents a largely undefined group of people with paralysis due to diseases such as spinal stenosis, cancer, infection, multiple sclerosis, or other non-traumatic causes.
As a result, the population with SCI/D is comprised primarily of young adult males who have relatively few chronic medical conditions at the time of their injury and age with SCI/D, and older patients who are more likely to have already developed chronic medical conditions by the time of their SCI/D. Approximately 60% of SCI/Ds result in tetraplegia (ie, 4 limbs affected), although approximately two-thirds are incomplete, meaning that patients have some residual motor or sensory function below the level of injury.2 Not surprisingly, the level and severity of SCI/D impact life expectancy inversely and lifetime financial costs directly.
High health care utilization. Morbidity data largely parallel mortality data, often resulting in high health care utilization and cost among SCI/D patients.28 In a recent prospective observational study of nearly 1000 people with new traumatic SCI, 36.2% were rehospitalized at least once and 12.5% were rehospitalized at least twice during the 12-month period after discharge following injury.29
Rehospitalization, an outcome often quoted as a proxy for inadequate primary care, remains unacceptably high (36%-50%) for people with SCI/D.29,30 The leading causes of rehospitalization—pneumonia, urinary tract infection (UTI), and pressure ulcers29—have not changed over the years and persist over the lifetime of individuals with SCI/D.30
Take steps to prevent pneumonia, other respiratory complications
Many people with SCI/D are at high risk for respiratory complications because of their weakened respiratory muscles. This is particularly true for individuals who have injuries occurring above T10; those with injuries that are high on the spinal cord have the highest complication risk.7,8 In fact, pneumonia, atelectasis, and other respiratory complications are the leading causes of mortality in patients with tetraplegia, occurring in 40% to 70% of these patients.7
The diaphragm, innervated by the phrenic nerve (C3-C5), is the primary muscle of inspiration. Accessory muscles of inspiration include the scalenes (C5-C8), sternocleidomastoid and trapezius (C1-C4), and intercostals (T1-T11); whereas forced exhalation (cough) occurs with contraction of the abdominals (T5-T12).9 Diminished inspiration in individuals with higher level lesions can lead to microatelectasis, dyspnea with exertion, and even respiratory insufficiency.
In SCI/D above T8, weakened expiration can severely decrease cough effectiveness and secretion clearance, increasing susceptibility to lower respiratory tract infections. In addition, experts have described asthma-like disorders of airway function, particularly in those with higher lesions, due to unopposed parasympathetic innervation of respiratory smooth muscle.10
Management of this neurogenic pulmonary dysfunction after SCI/D relies on extensive preventive measures, including positioning and postural changes, breathing techniques, coughing (assisted for patients with tetraplegia), postural drainage, chest compression and percussion, and suctioning to avoid atelectasis, aspiration, and pneumonia. Ensure that patients receive influenza and pneumococcal vaccinations, and encourage smoking cessation. Obtain a chest x-ray if the patient demonstrates a decrease in respiratory function, deteriorating vital signs, reduced vital capacity, an increase in subjective dyspnea, or a change in sputum quantity. Treat respiratory infections early and aggressively,7-10 and strongly consider inpatient management because of the high risk of respiratory failure.
Pneumococcus is the most common cause of respiratory infections, although up to 21% of cases of community-acquired pneumonia in patients with SCI/D are caused by Pseudomonas.11-13 Avoid the use of antibiotics in patients who do not have signs or symptoms of a respiratory infection to minimize the development of resistant organisms. Target antibiotic therapy as per general population guidelines, as guidelines validated for use in the population with SCI/D do not currently exist.7,11
Be alert for UTIs—typical signs, symptoms don’t apply
The bladder receives innervation from S2 to S4 via the hypogastric, pudendal, and pelvic nerves. As such, the vast majority—70% to 84%—of patients with SCI/D report some degree of bladder dysfunction.14 Generally, SCI/D contributes to a combination of a failure to empty the bladder and a failure to store urine. The former is more frequent and the latter occurs more often in people with bladder outlet flaccidity, which usually occurs with low injury, such as that of the lumbar spine.14
The majority of people with SCI/D who are unable to empty their bladder require the use of some type of bladder catheter, either intermittent, indwelling (urethral or suprapubic), or condom. The choice of bladder management technique depends on gender, hand function, body habitus, caregiver assistance, and medical comorbidities. People with SCI/D are at greater risk for bladder and renal stones, UTI, vesicoureteral reflux, and bladder cancer.15,16 That said, the risk of bladder and renal stones declines somewhat after the first 6 months following an injury due to an immobility-induced loss of calcium.
Patients with SCI/D are often found to have bacteruria and even pyuria, and although they are at high risk for recurrent UTIs, these can be difficult to diagnose because signs and symptoms may differ from those seen in people with neurologically intact bladders. Symptomatic UTIs may present with fever, hematuria, abdominal discomfort, and/or increased spasticity, among other symptoms. They may cause increased bouts of autonomic dysreflexia, malaise, or a change in functional status. One cannot rely on the typical symptoms of dysuria and increased urinary frequency in this patient population. Further, the Infectious Diseases Society of America (IDSA) states that cloudy or foul-smelling urine in adults with catheters is not a symptom or sign mandating treatment.17
Because there is a lack of consensus as to what constitutes UTI symptoms in patients with SCI/D, PCPs need to be aware of changes from baseline in patients; these, combined with urine dip and culture results, should guide initiation of treatment.16
Prophylactic antibiotics have no role in the prevention of UTIs in patients with SCI/D. The minimal benefits associated with prophylaxis are outweighed by the risks of increased bacterial resistance to antibiotics. Research shows no significant benefit associated with the use of non-antibiotic prophylaxis, including the use of cranberry products and mannose, but further studies are needed in this patient population.18
Focus on bowel function; it correlates with quality of life
Bowel dysfunction is nearly universal in patients with SCI/D. The enteric nervous system is modulated via the sympathetic, parasympathetic, and somatic systems, and intrinsic control occurs via the myenteric and submucosal plexi. The loss of volitional control of defecation can result in prolonged transit time, reduced colonic motility, fecal incontinence, and difficulty with evacuation.
Because bowel care and function are highly correlated with quality of life,19 recommend bowel emptying every day or every other day, as well as adequate fiber in the diet, intake of fluids, stool softeners, bulk forming agents, contact irritants (eg, bisacodyl), and prokinetic agents to achieve optimal bowel care.
Prevent and treat pressure ulcers whenever possible
Accompanying the paralysis associated with SCI/D is often some degree of sensory loss of pain, light touch, temperature, and/or proprioception. The combination of insensate skin, immobility, and sarcopenia with resultant body composition changes places individuals with SCI/D at high risk for skin breakdown.21,22 Blood flow and oxygen tension at the skin surface are also decreased in patients with SCI/D compared to those without, further contributing to the problem.21,23 Increased latency from the time of injury correlates with increased likelihood of pressure ulcer development.21,22,24
External risk factors for pressure ulcers include prolonged pressure exposure, or intense pressure over a short period, shear forces, poor nutrition, smoking, moisture, and immobility. The incidence of pressure ulcers in patients with SCI/D is 25% to 66%, compared with 0.38% in the general population.21,22 Research indicates that US hospitals spend $11 billion annually on the treatment of the condition.22
To minimize pressure ulcers in this population, perform a risk assessment, using, for example, the Spinal Cord Injury Pressure Ulcer Scale-Acute (SCIPUS-A) available at https://www.scireproject.com/outcome-measures-new/spinal-cord-injury-pressure-ulcer-scale-acute-scipus. In addition, recommend that patients use pressure redistribution surfaces for beds and wheelchairs, turn while in bed, perform frequent (approximately every 15-30 minutes) pressure reliefs, exercise or move regularly, and that they or a caregiver inspect the skin daily. If pressure ulcers do occur, start treatment immediately and document the stage of the ulcer.
Ensure that screening efforts go beyond what’s standard
Preventive care for patients with SCI/D is similar in many ways to that recommended for the general population. Screening for colorectal cancer,31 cervical cancer, and breast cancer32 should follow the same evidence-based intervals and age ranges suggested by groups such as the US Preventive Services Task Force (USPSTF). The only difference is to give special consideration to patients’ physical limitations and the set-up of exam rooms when scheduling and conducting procedures, such as Pap smears, colonoscopies, and mammograms.33,34
Bladder cancer. Because of the high risk for bladder cancer (ie, squamous cell carcinoma, as opposed to the more common transitional cell carcinoma) in this population, experts recommend annual cystoscopy for bladder cancer surveillance in patients who have had indwelling catheters for more than 5 to 10 years.35
Osteoporosis. Screening for osteoporosis is another preventive health area in which recommendations differ from those addressing the general population. Paralysis contributes to a decrease in mechanical stress on bone and to accelerated bone loss, and, thus, to osteoporosis.36
In patients with SCI/D, osteoporosis affects primarily weight-bearing areas below the injured lesion, such as the distal femur and proximal tibia. Fractures in patients with SCI/D may occur during minor trauma (eg, during transfers from wheelchair to bed). Although screening and treatment guidelines for osteoporosis in patients with SCI/D are not established, most experts recommend early screening and early and aggressive treatment.36
Depression reportedly occurs more frequently in individuals with SCI/D than in the general population,37,38 affecting adjustment, quality of life, and social, behavioral, and physical functioning. In light of this, it’s advisable to use screening tools, such as The Patient Health Questionnaire (PHQ)-9, routinely.39
Sexuality and sexual function are often adversely affected in both men and women with SCI/D. Loss of sensation in the sexual organs, combined with difficulty with positioning and mobility and bowel and bladder dysfunction, contribute not only to sexual dysfunction, but to lower self-esteem and altered body image.40
It is important to remember that fertility is often unaffected in women, so routine discussions about contraception with women who have SCI/D and who are sexually active are imperative. At the same time, male fertility is usually profoundly affected by SCI/D; patients and their partners who are interested in having children will require specialized interventions. Address sexuality and fertility during primary care visits and refer patients to counseling or specialists as necessary.41-43
SCI/D requires a whole-person approach
The care of individuals with SCI/D requires a holistic approach that takes into consideration physical, psychological, environmental, and interpersonal factors44,45 and involves ongoing support from a variety of specialists. FPs, with their whole-person orientation, can be instrumental in ensuring the successful rehabilitation of patients affected by SCI/D, and in helping individuals attain, preserve, and enhance their health and well-being.
CORRESPONDENCE
Ranit Mishori, MD, MHS, FAAFP, Georgetown University School of Medicine, 3900 Reservoir Road, NW, Pre-clinical Building GB-01D, Washington, DC 20007; [email protected].
1. Christopher and Dana Reeve Foundation. One degree of separation. Paralysis and spinal cord injury in the United States. Available at: https://www.heart.us/uploads/userfiles/files/one-degree-of-separation.pdf. Accessed April 23, 2015.
2. National Spinal Cord Injury Statistical Center. 2014 Annual Statistical Report-Complete public version. Available at: https://www.nscisc.uab.edu/reports. Accessed November 1, 2015.
3. van den Berg ME, Castellote JM, de Pedro-Cuesta J, et al. Survival after spinal cord injury: a systematic review. J Neurotrauma. 2010;27:1517-1528.
4. Smith KM, Naumann DN, McDiarmid AL, et al. Using developmental research to design innovative knowledge translation technology for spinal cord injury in primary care: Actionable Nuggets on SkillScribe. J Spinal Cord Med. 2014;37:582-588.
5. McColl MA, Aiken A, McColl A, et al. Primary care of people with spinal cord injury: scoping review. Can Fam Physician. 2012;58:1207-1216.
6. Francisco GE, Chae JC, DeLisa JA. Physiatry as a primary care specialty. Am J Phys Med Rehabil. 1995;74:186-192.
7. Consortium for Spinal Cord Medicine. Respiratory management following spinal cord injury: A clinical practice guideline for health-care professionals. Paralyzed Veterans of America. January 2005.
8. Weaver FM, Smith B, LaVela S, et al. Interventions to increase influenza vaccination rates in veterans with spinal cord injuries and disorders. J Spinal Cord Med. 2007;30:10-19.
9. McKinley WO, Jackson AB, Cardenas DD, et al. Long-term medical complications after traumatic spinal cord injury: A regional model systems analysis. Arch Phys Med Rehabil. 1999;80:1402-1410.
10. Cardozo CP. Respiratory complications of spinal cord injury. J Spinal Cord Med. 2007;30: 307-308.
11. Burns SP, Weaver FM, Parada JP, et al. Management of community-acquired pneumonia in persons with spinal cord injury. Spinal Cord. 2004;42:450-458.
12. Schilero GJ, Spungen AM, Bauman WA, et al. Pulmonary function and spinal cord injury. Respir Physiol Neurobiol. 2009;166:129-141.
13. Waites KB, Canupp KC, Chen Y, et al. Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine. J Spinal Cord Med. 2008;31: 53-59.
14. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012:816274.
15. Taweel W, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85-99.
16. Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am. 2011;95:111-120.
17. Hooten TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625-663.
18. Goets L, Klausner A. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am. 2014;25:605-618.
19. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997;78:S86-S102.
20. Paralyzed Veterans of America. Consortium for Spinal Cord Medicine. Neurogenic Bowel Management in Adults with Spinal Cord Injury. Available at: http://www.pva.org/site/c.ajIRK9NJbcJ2E/b.6305815/k.A19D/Publications.htm#CPG. Accessed October 30, 2015.
21. Groah SL, Schladen M, Pineda CG, et al. Prevention of Pressure Ulcers Among People With Spinal Cord Injury: A Systematic Review. PM R. 2015;7:613-636.
22. Consortium for Spinal Cord Medicine Clinical Practice Guidelines. Pressure ulcer prevention and treatment following spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med. 2001;24:S40-S101.
23. Kruger EA, Pires M, Ngann Y, et al. Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends. J Spinal Cord Med. 2013;36:572-585.
24. Schubart JR, Hilgart M, Lyder C. Pressure ulcer prevention and management in spinal cord-injured adults: analysis of educational needs. Adv Skin Wound Care. 2008;21:322-329.
25. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and treatment of pressure ulcers: quick reference guide. 2nd ed. Cambridge Media. 2014.
26. Ghaisas S, Pyatak EA, Blanche E, et al. Lifestyle changes and pressure ulcer prevention in adults with spinal cord injury in the pressure ulcer prevention study lifestyle intervention. Am J Occup Ther. 2015;69:6901290020p1-6901290020p10.
27. Groah SL, Charlifue S, Tate D, et al. Spinal cord injury and aging: challenges and recommendations for future research. Am J Phys Med Rehabil. 2012;91:80-93.
28. Noonan VK, Fallah N, Park SE, et al. Health care utilization in persons with traumatic spinal cord injury: the importance of multimorbidity and the impact on patient outcomes. Top Spinal Cord Inj Rehabil. 2014;20:289-301.
29. DeJong G, Tian W, Hsieh CH, et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil. 2013;94:S87-S97.
30. Cardenas DD, Hoffman JM, Kirshblum S, et al. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil. 2004;85:1757-1763.
31. Hayman AV, Guihan M, Fisher MJ, et al. Colonoscopy is high yield in spinal cord injury. J Spinal Cord Med. 2013;36:436-442.
32. Guilcher SJ, Newman A, Jaglal SB. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population. J Womens Health. 2010;19:57-63.
33. Lezzoni LI, Park ER, Kilbridge KL. Implications of mobility impairment on the diagnosis and treatment of breast cancer. J Womens Health. 2011;20:45-52.
34. Graham A, Savic G, Gardner B. Cervical and breast cancer screening in wheelchair dependent females. Spinal Cord. 1998;36:340-344.
35. Groah SL, Weitzenkamp DA, Lammertse DP, et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83:346-351.
36. Charmetant C, Phaner V, Condemine A, et al. Diagnosis and treatment of osteoporosis in spinal cord injury patients: a literature review. Ann Phys Rehabil Med. 2010;53:655-668.
37. Bombardier CH, Richards JS, Krause JS, et al. Symptoms of major depression in people with spinal cord injury: implications for screening. Arch Phys Med Rehabil. 2004;85:1749-1756.
38. Elliott TR. Studying depression following spinal cord injury: evidence, policy and practice. J Spinal Cord Med. 2015;38:584-586.
39. Kalpakjian CZ, Bombardier CH, Schomer K, et al. Measuring depression in persons with spinal cord injury: a systematic review. J Spinal Cord Med. 2009;32:6-24.
40. Courtois F, Charvier K. Sexual dysfunction in patients with spinal cord lesions. Handb Clin Neurol. 2015;130:225-245.
41. Kreuter M, Taft C, Siösteen A, et al. Women’s sexual functioning and sex life after spinal cord injury. Spinal Cord. 2011;49:154-160.
42. Fritz HA, Dillaway H, Lysack CL. “Don’t think paralysis takes away your womanhood”: Sexual intimacy after spinal cord injury. Am J Occup Ther. 2015;69:6902260030p1-6902260030p10.
43. Smith AE, Molton IR, McMullen K, et al. Sexual function, satisfaction, and use of aids for sexual activity in middle-aged adults with long-term physical disability. Top Spinal Cord Inj Rehabil. 2015;21:227-232.
44. Chiodo AE, Scelza WM, Kirshblum SC, et al. Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch Phys Med Rehabil. 2007;88:S76-S83.
45. Middleton JW, Ramakrishnan K, Cameron ID. Health Maintenance for Adults with Spinal Cord Injuries. NSW Agency for Clinical Innovation. Chatswood, NSW, Australia. February 2014. Available at: http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0007/155167/Health-Maintenance.pdf. Accessed November 1, 2015.
› Have a high index of suspicion for the leading causes of hospitalization among patients with spinal cord injury and disease (SCI/D). These include respiratory infections, urinary tract infections, and pressure ulcers. A
› Treat respiratory infections early and aggressively in patients with SCI/D; strongly consider inpatient management because of the high risk of respiratory failure. C
› Be alert to atypical signs and symptoms of urinary tract infection in patients with SCI/D, such as fever, chills, spasm, autonomic dysfunction, nausea and vomiting, abdominal discomfort, and fatigue. C
Strength of recommendation (SOR)
A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series
More than 5 million Americans are living with paralysis, and for nearly one in 4 of them the cause is spinal cord injury or disease (SCI/D).1 More common than multiple sclerosis (17%) as a cause for the loss of movement, SCI/D is second only to stroke (29%).1
The percentage of people living with paralysis due to SCI/D is increasing, partly because the population is aging and partly because management of infections has improved. Prior to the 1970s, life expectancy for people with SCI/D was significantly shortened, largely because of urologic and respiratory infections. But improved bladder management, in particular, has increased life expectancy—especially for the least severely injured.2 Respiratory diseases and septicemia remain the leading causes of death, but with increased longevity, other causes, such as endocrine, metabolic and nutritional diseases, accidents, nervous system diseases, and musculoskeletal disorders, are becoming increasingly common.2,3
Primary care’s pivotal role. Given the size of the population affected by SCI/D and the increase in life expectancy, family physicians (FPs) are more likely than ever before to care for these patients, most of whom have highly specific needs. However, little information about the primary care of patients with SCI/D exists. This patient population tends to consume a relatively large share of practices’ resources because of high case complexity.4
A recent Canadian report confirms our clinical experience that FPs report knowledge gaps in the area of SCI/D care, yet the same report found that 90% of people with SCI/D identify FPs as their “regular doctors.”5 Although a large number of patients with SCI/D identify their physiatrist as their primary care physician (PCP), one study reported that fewer than half of physiatrists are willing to assume that role.6 And while more than half of all patients with SCI/D have both specialists and PCPs involved in their care,5 communication breakdowns are a concern for patients receiving medical and rehabilitative direction from multiple health care professionals.
Below we take a closer look at the distinct patient populations affected by SCI/D, summarize several clinical conditions that contribute to hospitalization, and provide clinical management recommendations (TABLE7-26).
2 patient populations, one diagnosis
Paralysis due to spinal trauma occurs predominantly in non-Hispanic white and black males because of vehicular accidents, falls, violence, and sports.2 The mean age of injury has increased from 29 years during the 1970s to 42 years since 2010.2 However, this calculated average is misleading because there is an emerging bimodal distribution of people injured during early adulthood and a new increase in older adults injured primarily because of falls.27 In addition to those injured traumatically, a broader cohort of approximately 1 million patients represents a largely undefined group of people with paralysis due to diseases such as spinal stenosis, cancer, infection, multiple sclerosis, or other non-traumatic causes.
As a result, the population with SCI/D is comprised primarily of young adult males who have relatively few chronic medical conditions at the time of their injury and age with SCI/D, and older patients who are more likely to have already developed chronic medical conditions by the time of their SCI/D. Approximately 60% of SCI/Ds result in tetraplegia (ie, 4 limbs affected), although approximately two-thirds are incomplete, meaning that patients have some residual motor or sensory function below the level of injury.2 Not surprisingly, the level and severity of SCI/D impact life expectancy inversely and lifetime financial costs directly.
High health care utilization. Morbidity data largely parallel mortality data, often resulting in high health care utilization and cost among SCI/D patients.28 In a recent prospective observational study of nearly 1000 people with new traumatic SCI, 36.2% were rehospitalized at least once and 12.5% were rehospitalized at least twice during the 12-month period after discharge following injury.29
Rehospitalization, an outcome often quoted as a proxy for inadequate primary care, remains unacceptably high (36%-50%) for people with SCI/D.29,30 The leading causes of rehospitalization—pneumonia, urinary tract infection (UTI), and pressure ulcers29—have not changed over the years and persist over the lifetime of individuals with SCI/D.30
Take steps to prevent pneumonia, other respiratory complications
Many people with SCI/D are at high risk for respiratory complications because of their weakened respiratory muscles. This is particularly true for individuals who have injuries occurring above T10; those with injuries that are high on the spinal cord have the highest complication risk.7,8 In fact, pneumonia, atelectasis, and other respiratory complications are the leading causes of mortality in patients with tetraplegia, occurring in 40% to 70% of these patients.7
The diaphragm, innervated by the phrenic nerve (C3-C5), is the primary muscle of inspiration. Accessory muscles of inspiration include the scalenes (C5-C8), sternocleidomastoid and trapezius (C1-C4), and intercostals (T1-T11); whereas forced exhalation (cough) occurs with contraction of the abdominals (T5-T12).9 Diminished inspiration in individuals with higher level lesions can lead to microatelectasis, dyspnea with exertion, and even respiratory insufficiency.
In SCI/D above T8, weakened expiration can severely decrease cough effectiveness and secretion clearance, increasing susceptibility to lower respiratory tract infections. In addition, experts have described asthma-like disorders of airway function, particularly in those with higher lesions, due to unopposed parasympathetic innervation of respiratory smooth muscle.10
Management of this neurogenic pulmonary dysfunction after SCI/D relies on extensive preventive measures, including positioning and postural changes, breathing techniques, coughing (assisted for patients with tetraplegia), postural drainage, chest compression and percussion, and suctioning to avoid atelectasis, aspiration, and pneumonia. Ensure that patients receive influenza and pneumococcal vaccinations, and encourage smoking cessation. Obtain a chest x-ray if the patient demonstrates a decrease in respiratory function, deteriorating vital signs, reduced vital capacity, an increase in subjective dyspnea, or a change in sputum quantity. Treat respiratory infections early and aggressively,7-10 and strongly consider inpatient management because of the high risk of respiratory failure.
Pneumococcus is the most common cause of respiratory infections, although up to 21% of cases of community-acquired pneumonia in patients with SCI/D are caused by Pseudomonas.11-13 Avoid the use of antibiotics in patients who do not have signs or symptoms of a respiratory infection to minimize the development of resistant organisms. Target antibiotic therapy as per general population guidelines, as guidelines validated for use in the population with SCI/D do not currently exist.7,11
Be alert for UTIs—typical signs, symptoms don’t apply
The bladder receives innervation from S2 to S4 via the hypogastric, pudendal, and pelvic nerves. As such, the vast majority—70% to 84%—of patients with SCI/D report some degree of bladder dysfunction.14 Generally, SCI/D contributes to a combination of a failure to empty the bladder and a failure to store urine. The former is more frequent and the latter occurs more often in people with bladder outlet flaccidity, which usually occurs with low injury, such as that of the lumbar spine.14
The majority of people with SCI/D who are unable to empty their bladder require the use of some type of bladder catheter, either intermittent, indwelling (urethral or suprapubic), or condom. The choice of bladder management technique depends on gender, hand function, body habitus, caregiver assistance, and medical comorbidities. People with SCI/D are at greater risk for bladder and renal stones, UTI, vesicoureteral reflux, and bladder cancer.15,16 That said, the risk of bladder and renal stones declines somewhat after the first 6 months following an injury due to an immobility-induced loss of calcium.
Patients with SCI/D are often found to have bacteruria and even pyuria, and although they are at high risk for recurrent UTIs, these can be difficult to diagnose because signs and symptoms may differ from those seen in people with neurologically intact bladders. Symptomatic UTIs may present with fever, hematuria, abdominal discomfort, and/or increased spasticity, among other symptoms. They may cause increased bouts of autonomic dysreflexia, malaise, or a change in functional status. One cannot rely on the typical symptoms of dysuria and increased urinary frequency in this patient population. Further, the Infectious Diseases Society of America (IDSA) states that cloudy or foul-smelling urine in adults with catheters is not a symptom or sign mandating treatment.17
Because there is a lack of consensus as to what constitutes UTI symptoms in patients with SCI/D, PCPs need to be aware of changes from baseline in patients; these, combined with urine dip and culture results, should guide initiation of treatment.16
Prophylactic antibiotics have no role in the prevention of UTIs in patients with SCI/D. The minimal benefits associated with prophylaxis are outweighed by the risks of increased bacterial resistance to antibiotics. Research shows no significant benefit associated with the use of non-antibiotic prophylaxis, including the use of cranberry products and mannose, but further studies are needed in this patient population.18
Focus on bowel function; it correlates with quality of life
Bowel dysfunction is nearly universal in patients with SCI/D. The enteric nervous system is modulated via the sympathetic, parasympathetic, and somatic systems, and intrinsic control occurs via the myenteric and submucosal plexi. The loss of volitional control of defecation can result in prolonged transit time, reduced colonic motility, fecal incontinence, and difficulty with evacuation.
Because bowel care and function are highly correlated with quality of life,19 recommend bowel emptying every day or every other day, as well as adequate fiber in the diet, intake of fluids, stool softeners, bulk forming agents, contact irritants (eg, bisacodyl), and prokinetic agents to achieve optimal bowel care.
Prevent and treat pressure ulcers whenever possible
Accompanying the paralysis associated with SCI/D is often some degree of sensory loss of pain, light touch, temperature, and/or proprioception. The combination of insensate skin, immobility, and sarcopenia with resultant body composition changes places individuals with SCI/D at high risk for skin breakdown.21,22 Blood flow and oxygen tension at the skin surface are also decreased in patients with SCI/D compared to those without, further contributing to the problem.21,23 Increased latency from the time of injury correlates with increased likelihood of pressure ulcer development.21,22,24
External risk factors for pressure ulcers include prolonged pressure exposure, or intense pressure over a short period, shear forces, poor nutrition, smoking, moisture, and immobility. The incidence of pressure ulcers in patients with SCI/D is 25% to 66%, compared with 0.38% in the general population.21,22 Research indicates that US hospitals spend $11 billion annually on the treatment of the condition.22
To minimize pressure ulcers in this population, perform a risk assessment, using, for example, the Spinal Cord Injury Pressure Ulcer Scale-Acute (SCIPUS-A) available at https://www.scireproject.com/outcome-measures-new/spinal-cord-injury-pressure-ulcer-scale-acute-scipus. In addition, recommend that patients use pressure redistribution surfaces for beds and wheelchairs, turn while in bed, perform frequent (approximately every 15-30 minutes) pressure reliefs, exercise or move regularly, and that they or a caregiver inspect the skin daily. If pressure ulcers do occur, start treatment immediately and document the stage of the ulcer.
Ensure that screening efforts go beyond what’s standard
Preventive care for patients with SCI/D is similar in many ways to that recommended for the general population. Screening for colorectal cancer,31 cervical cancer, and breast cancer32 should follow the same evidence-based intervals and age ranges suggested by groups such as the US Preventive Services Task Force (USPSTF). The only difference is to give special consideration to patients’ physical limitations and the set-up of exam rooms when scheduling and conducting procedures, such as Pap smears, colonoscopies, and mammograms.33,34
Bladder cancer. Because of the high risk for bladder cancer (ie, squamous cell carcinoma, as opposed to the more common transitional cell carcinoma) in this population, experts recommend annual cystoscopy for bladder cancer surveillance in patients who have had indwelling catheters for more than 5 to 10 years.35
Osteoporosis. Screening for osteoporosis is another preventive health area in which recommendations differ from those addressing the general population. Paralysis contributes to a decrease in mechanical stress on bone and to accelerated bone loss, and, thus, to osteoporosis.36
In patients with SCI/D, osteoporosis affects primarily weight-bearing areas below the injured lesion, such as the distal femur and proximal tibia. Fractures in patients with SCI/D may occur during minor trauma (eg, during transfers from wheelchair to bed). Although screening and treatment guidelines for osteoporosis in patients with SCI/D are not established, most experts recommend early screening and early and aggressive treatment.36
Depression reportedly occurs more frequently in individuals with SCI/D than in the general population,37,38 affecting adjustment, quality of life, and social, behavioral, and physical functioning. In light of this, it’s advisable to use screening tools, such as The Patient Health Questionnaire (PHQ)-9, routinely.39
Sexuality and sexual function are often adversely affected in both men and women with SCI/D. Loss of sensation in the sexual organs, combined with difficulty with positioning and mobility and bowel and bladder dysfunction, contribute not only to sexual dysfunction, but to lower self-esteem and altered body image.40
It is important to remember that fertility is often unaffected in women, so routine discussions about contraception with women who have SCI/D and who are sexually active are imperative. At the same time, male fertility is usually profoundly affected by SCI/D; patients and their partners who are interested in having children will require specialized interventions. Address sexuality and fertility during primary care visits and refer patients to counseling or specialists as necessary.41-43
SCI/D requires a whole-person approach
The care of individuals with SCI/D requires a holistic approach that takes into consideration physical, psychological, environmental, and interpersonal factors44,45 and involves ongoing support from a variety of specialists. FPs, with their whole-person orientation, can be instrumental in ensuring the successful rehabilitation of patients affected by SCI/D, and in helping individuals attain, preserve, and enhance their health and well-being.
CORRESPONDENCE
Ranit Mishori, MD, MHS, FAAFP, Georgetown University School of Medicine, 3900 Reservoir Road, NW, Pre-clinical Building GB-01D, Washington, DC 20007; [email protected].
› Have a high index of suspicion for the leading causes of hospitalization among patients with spinal cord injury and disease (SCI/D). These include respiratory infections, urinary tract infections, and pressure ulcers. A
› Treat respiratory infections early and aggressively in patients with SCI/D; strongly consider inpatient management because of the high risk of respiratory failure. C
› Be alert to atypical signs and symptoms of urinary tract infection in patients with SCI/D, such as fever, chills, spasm, autonomic dysfunction, nausea and vomiting, abdominal discomfort, and fatigue. C
Strength of recommendation (SOR)
A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series
More than 5 million Americans are living with paralysis, and for nearly one in 4 of them the cause is spinal cord injury or disease (SCI/D).1 More common than multiple sclerosis (17%) as a cause for the loss of movement, SCI/D is second only to stroke (29%).1
The percentage of people living with paralysis due to SCI/D is increasing, partly because the population is aging and partly because management of infections has improved. Prior to the 1970s, life expectancy for people with SCI/D was significantly shortened, largely because of urologic and respiratory infections. But improved bladder management, in particular, has increased life expectancy—especially for the least severely injured.2 Respiratory diseases and septicemia remain the leading causes of death, but with increased longevity, other causes, such as endocrine, metabolic and nutritional diseases, accidents, nervous system diseases, and musculoskeletal disorders, are becoming increasingly common.2,3
Primary care’s pivotal role. Given the size of the population affected by SCI/D and the increase in life expectancy, family physicians (FPs) are more likely than ever before to care for these patients, most of whom have highly specific needs. However, little information about the primary care of patients with SCI/D exists. This patient population tends to consume a relatively large share of practices’ resources because of high case complexity.4
A recent Canadian report confirms our clinical experience that FPs report knowledge gaps in the area of SCI/D care, yet the same report found that 90% of people with SCI/D identify FPs as their “regular doctors.”5 Although a large number of patients with SCI/D identify their physiatrist as their primary care physician (PCP), one study reported that fewer than half of physiatrists are willing to assume that role.6 And while more than half of all patients with SCI/D have both specialists and PCPs involved in their care,5 communication breakdowns are a concern for patients receiving medical and rehabilitative direction from multiple health care professionals.
Below we take a closer look at the distinct patient populations affected by SCI/D, summarize several clinical conditions that contribute to hospitalization, and provide clinical management recommendations (TABLE7-26).
2 patient populations, one diagnosis
Paralysis due to spinal trauma occurs predominantly in non-Hispanic white and black males because of vehicular accidents, falls, violence, and sports.2 The mean age of injury has increased from 29 years during the 1970s to 42 years since 2010.2 However, this calculated average is misleading because there is an emerging bimodal distribution of people injured during early adulthood and a new increase in older adults injured primarily because of falls.27 In addition to those injured traumatically, a broader cohort of approximately 1 million patients represents a largely undefined group of people with paralysis due to diseases such as spinal stenosis, cancer, infection, multiple sclerosis, or other non-traumatic causes.
As a result, the population with SCI/D is comprised primarily of young adult males who have relatively few chronic medical conditions at the time of their injury and age with SCI/D, and older patients who are more likely to have already developed chronic medical conditions by the time of their SCI/D. Approximately 60% of SCI/Ds result in tetraplegia (ie, 4 limbs affected), although approximately two-thirds are incomplete, meaning that patients have some residual motor or sensory function below the level of injury.2 Not surprisingly, the level and severity of SCI/D impact life expectancy inversely and lifetime financial costs directly.
High health care utilization. Morbidity data largely parallel mortality data, often resulting in high health care utilization and cost among SCI/D patients.28 In a recent prospective observational study of nearly 1000 people with new traumatic SCI, 36.2% were rehospitalized at least once and 12.5% were rehospitalized at least twice during the 12-month period after discharge following injury.29
Rehospitalization, an outcome often quoted as a proxy for inadequate primary care, remains unacceptably high (36%-50%) for people with SCI/D.29,30 The leading causes of rehospitalization—pneumonia, urinary tract infection (UTI), and pressure ulcers29—have not changed over the years and persist over the lifetime of individuals with SCI/D.30
Take steps to prevent pneumonia, other respiratory complications
Many people with SCI/D are at high risk for respiratory complications because of their weakened respiratory muscles. This is particularly true for individuals who have injuries occurring above T10; those with injuries that are high on the spinal cord have the highest complication risk.7,8 In fact, pneumonia, atelectasis, and other respiratory complications are the leading causes of mortality in patients with tetraplegia, occurring in 40% to 70% of these patients.7
The diaphragm, innervated by the phrenic nerve (C3-C5), is the primary muscle of inspiration. Accessory muscles of inspiration include the scalenes (C5-C8), sternocleidomastoid and trapezius (C1-C4), and intercostals (T1-T11); whereas forced exhalation (cough) occurs with contraction of the abdominals (T5-T12).9 Diminished inspiration in individuals with higher level lesions can lead to microatelectasis, dyspnea with exertion, and even respiratory insufficiency.
In SCI/D above T8, weakened expiration can severely decrease cough effectiveness and secretion clearance, increasing susceptibility to lower respiratory tract infections. In addition, experts have described asthma-like disorders of airway function, particularly in those with higher lesions, due to unopposed parasympathetic innervation of respiratory smooth muscle.10
Management of this neurogenic pulmonary dysfunction after SCI/D relies on extensive preventive measures, including positioning and postural changes, breathing techniques, coughing (assisted for patients with tetraplegia), postural drainage, chest compression and percussion, and suctioning to avoid atelectasis, aspiration, and pneumonia. Ensure that patients receive influenza and pneumococcal vaccinations, and encourage smoking cessation. Obtain a chest x-ray if the patient demonstrates a decrease in respiratory function, deteriorating vital signs, reduced vital capacity, an increase in subjective dyspnea, or a change in sputum quantity. Treat respiratory infections early and aggressively,7-10 and strongly consider inpatient management because of the high risk of respiratory failure.
Pneumococcus is the most common cause of respiratory infections, although up to 21% of cases of community-acquired pneumonia in patients with SCI/D are caused by Pseudomonas.11-13 Avoid the use of antibiotics in patients who do not have signs or symptoms of a respiratory infection to minimize the development of resistant organisms. Target antibiotic therapy as per general population guidelines, as guidelines validated for use in the population with SCI/D do not currently exist.7,11
Be alert for UTIs—typical signs, symptoms don’t apply
The bladder receives innervation from S2 to S4 via the hypogastric, pudendal, and pelvic nerves. As such, the vast majority—70% to 84%—of patients with SCI/D report some degree of bladder dysfunction.14 Generally, SCI/D contributes to a combination of a failure to empty the bladder and a failure to store urine. The former is more frequent and the latter occurs more often in people with bladder outlet flaccidity, which usually occurs with low injury, such as that of the lumbar spine.14
The majority of people with SCI/D who are unable to empty their bladder require the use of some type of bladder catheter, either intermittent, indwelling (urethral or suprapubic), or condom. The choice of bladder management technique depends on gender, hand function, body habitus, caregiver assistance, and medical comorbidities. People with SCI/D are at greater risk for bladder and renal stones, UTI, vesicoureteral reflux, and bladder cancer.15,16 That said, the risk of bladder and renal stones declines somewhat after the first 6 months following an injury due to an immobility-induced loss of calcium.
Patients with SCI/D are often found to have bacteruria and even pyuria, and although they are at high risk for recurrent UTIs, these can be difficult to diagnose because signs and symptoms may differ from those seen in people with neurologically intact bladders. Symptomatic UTIs may present with fever, hematuria, abdominal discomfort, and/or increased spasticity, among other symptoms. They may cause increased bouts of autonomic dysreflexia, malaise, or a change in functional status. One cannot rely on the typical symptoms of dysuria and increased urinary frequency in this patient population. Further, the Infectious Diseases Society of America (IDSA) states that cloudy or foul-smelling urine in adults with catheters is not a symptom or sign mandating treatment.17
Because there is a lack of consensus as to what constitutes UTI symptoms in patients with SCI/D, PCPs need to be aware of changes from baseline in patients; these, combined with urine dip and culture results, should guide initiation of treatment.16
Prophylactic antibiotics have no role in the prevention of UTIs in patients with SCI/D. The minimal benefits associated with prophylaxis are outweighed by the risks of increased bacterial resistance to antibiotics. Research shows no significant benefit associated with the use of non-antibiotic prophylaxis, including the use of cranberry products and mannose, but further studies are needed in this patient population.18
Focus on bowel function; it correlates with quality of life
Bowel dysfunction is nearly universal in patients with SCI/D. The enteric nervous system is modulated via the sympathetic, parasympathetic, and somatic systems, and intrinsic control occurs via the myenteric and submucosal plexi. The loss of volitional control of defecation can result in prolonged transit time, reduced colonic motility, fecal incontinence, and difficulty with evacuation.
Because bowel care and function are highly correlated with quality of life,19 recommend bowel emptying every day or every other day, as well as adequate fiber in the diet, intake of fluids, stool softeners, bulk forming agents, contact irritants (eg, bisacodyl), and prokinetic agents to achieve optimal bowel care.
Prevent and treat pressure ulcers whenever possible
Accompanying the paralysis associated with SCI/D is often some degree of sensory loss of pain, light touch, temperature, and/or proprioception. The combination of insensate skin, immobility, and sarcopenia with resultant body composition changes places individuals with SCI/D at high risk for skin breakdown.21,22 Blood flow and oxygen tension at the skin surface are also decreased in patients with SCI/D compared to those without, further contributing to the problem.21,23 Increased latency from the time of injury correlates with increased likelihood of pressure ulcer development.21,22,24
External risk factors for pressure ulcers include prolonged pressure exposure, or intense pressure over a short period, shear forces, poor nutrition, smoking, moisture, and immobility. The incidence of pressure ulcers in patients with SCI/D is 25% to 66%, compared with 0.38% in the general population.21,22 Research indicates that US hospitals spend $11 billion annually on the treatment of the condition.22
To minimize pressure ulcers in this population, perform a risk assessment, using, for example, the Spinal Cord Injury Pressure Ulcer Scale-Acute (SCIPUS-A) available at https://www.scireproject.com/outcome-measures-new/spinal-cord-injury-pressure-ulcer-scale-acute-scipus. In addition, recommend that patients use pressure redistribution surfaces for beds and wheelchairs, turn while in bed, perform frequent (approximately every 15-30 minutes) pressure reliefs, exercise or move regularly, and that they or a caregiver inspect the skin daily. If pressure ulcers do occur, start treatment immediately and document the stage of the ulcer.
Ensure that screening efforts go beyond what’s standard
Preventive care for patients with SCI/D is similar in many ways to that recommended for the general population. Screening for colorectal cancer,31 cervical cancer, and breast cancer32 should follow the same evidence-based intervals and age ranges suggested by groups such as the US Preventive Services Task Force (USPSTF). The only difference is to give special consideration to patients’ physical limitations and the set-up of exam rooms when scheduling and conducting procedures, such as Pap smears, colonoscopies, and mammograms.33,34
Bladder cancer. Because of the high risk for bladder cancer (ie, squamous cell carcinoma, as opposed to the more common transitional cell carcinoma) in this population, experts recommend annual cystoscopy for bladder cancer surveillance in patients who have had indwelling catheters for more than 5 to 10 years.35
Osteoporosis. Screening for osteoporosis is another preventive health area in which recommendations differ from those addressing the general population. Paralysis contributes to a decrease in mechanical stress on bone and to accelerated bone loss, and, thus, to osteoporosis.36
In patients with SCI/D, osteoporosis affects primarily weight-bearing areas below the injured lesion, such as the distal femur and proximal tibia. Fractures in patients with SCI/D may occur during minor trauma (eg, during transfers from wheelchair to bed). Although screening and treatment guidelines for osteoporosis in patients with SCI/D are not established, most experts recommend early screening and early and aggressive treatment.36
Depression reportedly occurs more frequently in individuals with SCI/D than in the general population,37,38 affecting adjustment, quality of life, and social, behavioral, and physical functioning. In light of this, it’s advisable to use screening tools, such as The Patient Health Questionnaire (PHQ)-9, routinely.39
Sexuality and sexual function are often adversely affected in both men and women with SCI/D. Loss of sensation in the sexual organs, combined with difficulty with positioning and mobility and bowel and bladder dysfunction, contribute not only to sexual dysfunction, but to lower self-esteem and altered body image.40
It is important to remember that fertility is often unaffected in women, so routine discussions about contraception with women who have SCI/D and who are sexually active are imperative. At the same time, male fertility is usually profoundly affected by SCI/D; patients and their partners who are interested in having children will require specialized interventions. Address sexuality and fertility during primary care visits and refer patients to counseling or specialists as necessary.41-43
SCI/D requires a whole-person approach
The care of individuals with SCI/D requires a holistic approach that takes into consideration physical, psychological, environmental, and interpersonal factors44,45 and involves ongoing support from a variety of specialists. FPs, with their whole-person orientation, can be instrumental in ensuring the successful rehabilitation of patients affected by SCI/D, and in helping individuals attain, preserve, and enhance their health and well-being.
CORRESPONDENCE
Ranit Mishori, MD, MHS, FAAFP, Georgetown University School of Medicine, 3900 Reservoir Road, NW, Pre-clinical Building GB-01D, Washington, DC 20007; [email protected].
1. Christopher and Dana Reeve Foundation. One degree of separation. Paralysis and spinal cord injury in the United States. Available at: https://www.heart.us/uploads/userfiles/files/one-degree-of-separation.pdf. Accessed April 23, 2015.
2. National Spinal Cord Injury Statistical Center. 2014 Annual Statistical Report-Complete public version. Available at: https://www.nscisc.uab.edu/reports. Accessed November 1, 2015.
3. van den Berg ME, Castellote JM, de Pedro-Cuesta J, et al. Survival after spinal cord injury: a systematic review. J Neurotrauma. 2010;27:1517-1528.
4. Smith KM, Naumann DN, McDiarmid AL, et al. Using developmental research to design innovative knowledge translation technology for spinal cord injury in primary care: Actionable Nuggets on SkillScribe. J Spinal Cord Med. 2014;37:582-588.
5. McColl MA, Aiken A, McColl A, et al. Primary care of people with spinal cord injury: scoping review. Can Fam Physician. 2012;58:1207-1216.
6. Francisco GE, Chae JC, DeLisa JA. Physiatry as a primary care specialty. Am J Phys Med Rehabil. 1995;74:186-192.
7. Consortium for Spinal Cord Medicine. Respiratory management following spinal cord injury: A clinical practice guideline for health-care professionals. Paralyzed Veterans of America. January 2005.
8. Weaver FM, Smith B, LaVela S, et al. Interventions to increase influenza vaccination rates in veterans with spinal cord injuries and disorders. J Spinal Cord Med. 2007;30:10-19.
9. McKinley WO, Jackson AB, Cardenas DD, et al. Long-term medical complications after traumatic spinal cord injury: A regional model systems analysis. Arch Phys Med Rehabil. 1999;80:1402-1410.
10. Cardozo CP. Respiratory complications of spinal cord injury. J Spinal Cord Med. 2007;30: 307-308.
11. Burns SP, Weaver FM, Parada JP, et al. Management of community-acquired pneumonia in persons with spinal cord injury. Spinal Cord. 2004;42:450-458.
12. Schilero GJ, Spungen AM, Bauman WA, et al. Pulmonary function and spinal cord injury. Respir Physiol Neurobiol. 2009;166:129-141.
13. Waites KB, Canupp KC, Chen Y, et al. Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine. J Spinal Cord Med. 2008;31: 53-59.
14. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012:816274.
15. Taweel W, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85-99.
16. Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am. 2011;95:111-120.
17. Hooten TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625-663.
18. Goets L, Klausner A. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am. 2014;25:605-618.
19. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997;78:S86-S102.
20. Paralyzed Veterans of America. Consortium for Spinal Cord Medicine. Neurogenic Bowel Management in Adults with Spinal Cord Injury. Available at: http://www.pva.org/site/c.ajIRK9NJbcJ2E/b.6305815/k.A19D/Publications.htm#CPG. Accessed October 30, 2015.
21. Groah SL, Schladen M, Pineda CG, et al. Prevention of Pressure Ulcers Among People With Spinal Cord Injury: A Systematic Review. PM R. 2015;7:613-636.
22. Consortium for Spinal Cord Medicine Clinical Practice Guidelines. Pressure ulcer prevention and treatment following spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med. 2001;24:S40-S101.
23. Kruger EA, Pires M, Ngann Y, et al. Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends. J Spinal Cord Med. 2013;36:572-585.
24. Schubart JR, Hilgart M, Lyder C. Pressure ulcer prevention and management in spinal cord-injured adults: analysis of educational needs. Adv Skin Wound Care. 2008;21:322-329.
25. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and treatment of pressure ulcers: quick reference guide. 2nd ed. Cambridge Media. 2014.
26. Ghaisas S, Pyatak EA, Blanche E, et al. Lifestyle changes and pressure ulcer prevention in adults with spinal cord injury in the pressure ulcer prevention study lifestyle intervention. Am J Occup Ther. 2015;69:6901290020p1-6901290020p10.
27. Groah SL, Charlifue S, Tate D, et al. Spinal cord injury and aging: challenges and recommendations for future research. Am J Phys Med Rehabil. 2012;91:80-93.
28. Noonan VK, Fallah N, Park SE, et al. Health care utilization in persons with traumatic spinal cord injury: the importance of multimorbidity and the impact on patient outcomes. Top Spinal Cord Inj Rehabil. 2014;20:289-301.
29. DeJong G, Tian W, Hsieh CH, et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil. 2013;94:S87-S97.
30. Cardenas DD, Hoffman JM, Kirshblum S, et al. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil. 2004;85:1757-1763.
31. Hayman AV, Guihan M, Fisher MJ, et al. Colonoscopy is high yield in spinal cord injury. J Spinal Cord Med. 2013;36:436-442.
32. Guilcher SJ, Newman A, Jaglal SB. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population. J Womens Health. 2010;19:57-63.
33. Lezzoni LI, Park ER, Kilbridge KL. Implications of mobility impairment on the diagnosis and treatment of breast cancer. J Womens Health. 2011;20:45-52.
34. Graham A, Savic G, Gardner B. Cervical and breast cancer screening in wheelchair dependent females. Spinal Cord. 1998;36:340-344.
35. Groah SL, Weitzenkamp DA, Lammertse DP, et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83:346-351.
36. Charmetant C, Phaner V, Condemine A, et al. Diagnosis and treatment of osteoporosis in spinal cord injury patients: a literature review. Ann Phys Rehabil Med. 2010;53:655-668.
37. Bombardier CH, Richards JS, Krause JS, et al. Symptoms of major depression in people with spinal cord injury: implications for screening. Arch Phys Med Rehabil. 2004;85:1749-1756.
38. Elliott TR. Studying depression following spinal cord injury: evidence, policy and practice. J Spinal Cord Med. 2015;38:584-586.
39. Kalpakjian CZ, Bombardier CH, Schomer K, et al. Measuring depression in persons with spinal cord injury: a systematic review. J Spinal Cord Med. 2009;32:6-24.
40. Courtois F, Charvier K. Sexual dysfunction in patients with spinal cord lesions. Handb Clin Neurol. 2015;130:225-245.
41. Kreuter M, Taft C, Siösteen A, et al. Women’s sexual functioning and sex life after spinal cord injury. Spinal Cord. 2011;49:154-160.
42. Fritz HA, Dillaway H, Lysack CL. “Don’t think paralysis takes away your womanhood”: Sexual intimacy after spinal cord injury. Am J Occup Ther. 2015;69:6902260030p1-6902260030p10.
43. Smith AE, Molton IR, McMullen K, et al. Sexual function, satisfaction, and use of aids for sexual activity in middle-aged adults with long-term physical disability. Top Spinal Cord Inj Rehabil. 2015;21:227-232.
44. Chiodo AE, Scelza WM, Kirshblum SC, et al. Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch Phys Med Rehabil. 2007;88:S76-S83.
45. Middleton JW, Ramakrishnan K, Cameron ID. Health Maintenance for Adults with Spinal Cord Injuries. NSW Agency for Clinical Innovation. Chatswood, NSW, Australia. February 2014. Available at: http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0007/155167/Health-Maintenance.pdf. Accessed November 1, 2015.
1. Christopher and Dana Reeve Foundation. One degree of separation. Paralysis and spinal cord injury in the United States. Available at: https://www.heart.us/uploads/userfiles/files/one-degree-of-separation.pdf. Accessed April 23, 2015.
2. National Spinal Cord Injury Statistical Center. 2014 Annual Statistical Report-Complete public version. Available at: https://www.nscisc.uab.edu/reports. Accessed November 1, 2015.
3. van den Berg ME, Castellote JM, de Pedro-Cuesta J, et al. Survival after spinal cord injury: a systematic review. J Neurotrauma. 2010;27:1517-1528.
4. Smith KM, Naumann DN, McDiarmid AL, et al. Using developmental research to design innovative knowledge translation technology for spinal cord injury in primary care: Actionable Nuggets on SkillScribe. J Spinal Cord Med. 2014;37:582-588.
5. McColl MA, Aiken A, McColl A, et al. Primary care of people with spinal cord injury: scoping review. Can Fam Physician. 2012;58:1207-1216.
6. Francisco GE, Chae JC, DeLisa JA. Physiatry as a primary care specialty. Am J Phys Med Rehabil. 1995;74:186-192.
7. Consortium for Spinal Cord Medicine. Respiratory management following spinal cord injury: A clinical practice guideline for health-care professionals. Paralyzed Veterans of America. January 2005.
8. Weaver FM, Smith B, LaVela S, et al. Interventions to increase influenza vaccination rates in veterans with spinal cord injuries and disorders. J Spinal Cord Med. 2007;30:10-19.
9. McKinley WO, Jackson AB, Cardenas DD, et al. Long-term medical complications after traumatic spinal cord injury: A regional model systems analysis. Arch Phys Med Rehabil. 1999;80:1402-1410.
10. Cardozo CP. Respiratory complications of spinal cord injury. J Spinal Cord Med. 2007;30: 307-308.
11. Burns SP, Weaver FM, Parada JP, et al. Management of community-acquired pneumonia in persons with spinal cord injury. Spinal Cord. 2004;42:450-458.
12. Schilero GJ, Spungen AM, Bauman WA, et al. Pulmonary function and spinal cord injury. Respir Physiol Neurobiol. 2009;166:129-141.
13. Waites KB, Canupp KC, Chen Y, et al. Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine. J Spinal Cord Med. 2008;31: 53-59.
14. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012:816274.
15. Taweel W, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85-99.
16. Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am. 2011;95:111-120.
17. Hooten TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625-663.
18. Goets L, Klausner A. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am. 2014;25:605-618.
19. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997;78:S86-S102.
20. Paralyzed Veterans of America. Consortium for Spinal Cord Medicine. Neurogenic Bowel Management in Adults with Spinal Cord Injury. Available at: http://www.pva.org/site/c.ajIRK9NJbcJ2E/b.6305815/k.A19D/Publications.htm#CPG. Accessed October 30, 2015.
21. Groah SL, Schladen M, Pineda CG, et al. Prevention of Pressure Ulcers Among People With Spinal Cord Injury: A Systematic Review. PM R. 2015;7:613-636.
22. Consortium for Spinal Cord Medicine Clinical Practice Guidelines. Pressure ulcer prevention and treatment following spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med. 2001;24:S40-S101.
23. Kruger EA, Pires M, Ngann Y, et al. Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends. J Spinal Cord Med. 2013;36:572-585.
24. Schubart JR, Hilgart M, Lyder C. Pressure ulcer prevention and management in spinal cord-injured adults: analysis of educational needs. Adv Skin Wound Care. 2008;21:322-329.
25. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and treatment of pressure ulcers: quick reference guide. 2nd ed. Cambridge Media. 2014.
26. Ghaisas S, Pyatak EA, Blanche E, et al. Lifestyle changes and pressure ulcer prevention in adults with spinal cord injury in the pressure ulcer prevention study lifestyle intervention. Am J Occup Ther. 2015;69:6901290020p1-6901290020p10.
27. Groah SL, Charlifue S, Tate D, et al. Spinal cord injury and aging: challenges and recommendations for future research. Am J Phys Med Rehabil. 2012;91:80-93.
28. Noonan VK, Fallah N, Park SE, et al. Health care utilization in persons with traumatic spinal cord injury: the importance of multimorbidity and the impact on patient outcomes. Top Spinal Cord Inj Rehabil. 2014;20:289-301.
29. DeJong G, Tian W, Hsieh CH, et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil. 2013;94:S87-S97.
30. Cardenas DD, Hoffman JM, Kirshblum S, et al. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil. 2004;85:1757-1763.
31. Hayman AV, Guihan M, Fisher MJ, et al. Colonoscopy is high yield in spinal cord injury. J Spinal Cord Med. 2013;36:436-442.
32. Guilcher SJ, Newman A, Jaglal SB. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population. J Womens Health. 2010;19:57-63.
33. Lezzoni LI, Park ER, Kilbridge KL. Implications of mobility impairment on the diagnosis and treatment of breast cancer. J Womens Health. 2011;20:45-52.
34. Graham A, Savic G, Gardner B. Cervical and breast cancer screening in wheelchair dependent females. Spinal Cord. 1998;36:340-344.
35. Groah SL, Weitzenkamp DA, Lammertse DP, et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83:346-351.
36. Charmetant C, Phaner V, Condemine A, et al. Diagnosis and treatment of osteoporosis in spinal cord injury patients: a literature review. Ann Phys Rehabil Med. 2010;53:655-668.
37. Bombardier CH, Richards JS, Krause JS, et al. Symptoms of major depression in people with spinal cord injury: implications for screening. Arch Phys Med Rehabil. 2004;85:1749-1756.
38. Elliott TR. Studying depression following spinal cord injury: evidence, policy and practice. J Spinal Cord Med. 2015;38:584-586.
39. Kalpakjian CZ, Bombardier CH, Schomer K, et al. Measuring depression in persons with spinal cord injury: a systematic review. J Spinal Cord Med. 2009;32:6-24.
40. Courtois F, Charvier K. Sexual dysfunction in patients with spinal cord lesions. Handb Clin Neurol. 2015;130:225-245.
41. Kreuter M, Taft C, Siösteen A, et al. Women’s sexual functioning and sex life after spinal cord injury. Spinal Cord. 2011;49:154-160.
42. Fritz HA, Dillaway H, Lysack CL. “Don’t think paralysis takes away your womanhood”: Sexual intimacy after spinal cord injury. Am J Occup Ther. 2015;69:6902260030p1-6902260030p10.
43. Smith AE, Molton IR, McMullen K, et al. Sexual function, satisfaction, and use of aids for sexual activity in middle-aged adults with long-term physical disability. Top Spinal Cord Inj Rehabil. 2015;21:227-232.
44. Chiodo AE, Scelza WM, Kirshblum SC, et al. Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch Phys Med Rehabil. 2007;88:S76-S83.
45. Middleton JW, Ramakrishnan K, Cameron ID. Health Maintenance for Adults with Spinal Cord Injuries. NSW Agency for Clinical Innovation. Chatswood, NSW, Australia. February 2014. Available at: http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0007/155167/Health-Maintenance.pdf. Accessed November 1, 2015.
From The Journal of Family Practice | 2016;65(5):302-306,308-309.